DK3179986T3 - Tørpulverformuleringer til inhalation - Google Patents
Tørpulverformuleringer til inhalation Download PDFInfo
- Publication number
- DK3179986T3 DK3179986T3 DK15827152.8T DK15827152T DK3179986T3 DK 3179986 T3 DK3179986 T3 DK 3179986T3 DK 15827152 T DK15827152 T DK 15827152T DK 3179986 T3 DK3179986 T3 DK 3179986T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhalation
- dry powder
- powder formulations
- formulations
- dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462031811P | 2014-07-31 | 2014-07-31 | |
| PCT/US2015/043128 WO2016019253A1 (en) | 2014-07-31 | 2015-07-31 | Dry powder formulations for inhalation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3179986T3 true DK3179986T3 (da) | 2023-05-01 |
Family
ID=55218356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15827152.8T DK3179986T3 (da) | 2014-07-31 | 2015-07-31 | Tørpulverformuleringer til inhalation |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP4218734A1 (https=) |
| JP (1) | JP6850524B2 (https=) |
| KR (2) | KR102603897B1 (https=) |
| CN (2) | CN116687887A (https=) |
| AU (2) | AU2015296142A1 (https=) |
| CA (1) | CA2991760C (https=) |
| DK (1) | DK3179986T3 (https=) |
| ES (1) | ES2942297T3 (https=) |
| PL (1) | PL3179986T3 (https=) |
| WO (1) | WO2016019253A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016176552A1 (en) * | 2015-04-30 | 2016-11-03 | Otitopic Inc. | Dry power formulations for inhalation |
| EP3463378A4 (en) * | 2016-06-03 | 2020-01-08 | Otitopic Inc. | DRY POWDER FORMULAS FOR INHALATION |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| JP7493449B2 (ja) * | 2017-09-22 | 2024-05-31 | ヴェクチュラ インコーポレイテッド | ステアリン酸マグネシウムを含む乾燥粉末組成物 |
| EP4311566A1 (en) | 2022-07-28 | 2024-01-31 | Vectura Inc. | An inhaler comprising a retention element |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
| HU219899B (hu) | 1995-04-14 | 2001-09-28 | Glaxo Wellcome Inc. | Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban |
| ATE287703T1 (de) | 1995-04-14 | 2005-02-15 | Nektar Therapeutics | Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| WO1998055104A1 (fr) * | 1997-06-06 | 1998-12-10 | Shionogi & Co., Ltd. | Perfectionnement d'un systeme d'administration de medicament |
| US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| AU756693B2 (en) | 1997-09-29 | 2003-01-23 | Novartis Ag | Stabilized bioactive preparations and methods of use |
| GB9807232D0 (en) | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
| WO2000000215A1 (en) | 1998-06-29 | 2000-01-06 | Inhale Therapeutic Systems, Inc. | Particulate delivery systems and methods of use |
| GB9814172D0 (en) | 1998-06-30 | 1998-08-26 | Andaris Ltd | Formulation for inhalation |
| US7871598B1 (en) * | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| JP5698423B2 (ja) * | 2000-06-27 | 2015-04-08 | ベクトゥラ・リミテッド | 医薬組成物で使用するための粒子の製造法 |
| AU2002352836B2 (en) | 2001-11-20 | 2005-09-29 | Alkermes, Inc. | Improved particulate compositions for pulmonary delivery |
| GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
| US20040105821A1 (en) * | 2002-09-30 | 2004-06-03 | Howard Bernstein | Sustained release pharmaceutical formulation for inhalation |
| WO2005115341A2 (en) | 2004-05-27 | 2005-12-08 | Advanced Bionutrition Corporation | Microparticles for oral delivery |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| MX2007012045A (es) | 2005-03-28 | 2008-01-16 | Pericor Therapeutics Inc | Composiciones y formulaciones para evitar o reducir efectos adversos a un paciente. |
| MX2007015882A (es) * | 2005-06-13 | 2008-03-04 | Elan Pharma Int Ltd | Formulaciones en combinacion nanoparticulada de clopidogrel y aspirina. |
| GB0621957D0 (en) | 2006-11-03 | 2006-12-13 | Vectura Group Plc | Inhaler devices and bespoke pharmaceutical compositions |
| US8614255B2 (en) | 2007-08-21 | 2013-12-24 | Civitas Therapeutics, Inc. | Pulmonary pharmaceutical formulations |
| AU2009214443B2 (en) | 2008-02-13 | 2013-10-10 | Board Of Regents, The University Of Texas System | Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| US20120160944A1 (en) | 2009-04-24 | 2012-06-28 | Aaron Dodd | Method for the production of commercial nanoparticle and micro particle powders |
| GB201102237D0 (en) * | 2011-02-09 | 2011-03-23 | Kuecept Ltd | Particle formulation |
| US9216527B2 (en) | 2012-02-09 | 2015-12-22 | G & W Electric Company | Solid-dielectric switch including a molded viewing window |
| NZ629438A (en) * | 2012-02-28 | 2016-10-28 | Iceutica Holdings Inc | Inhalable pharmaceutical compositions |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| AU2013388034B2 (en) * | 2013-04-30 | 2019-08-15 | Aspeya US Inc. | Dry powder formulations and methods of use |
| CN112656780A (zh) | 2014-02-20 | 2021-04-16 | 奥迪托皮克股份有限公司 | 用于吸入的干粉制剂 |
-
2015
- 2015-07-31 EP EP23154329.9A patent/EP4218734A1/en active Pending
- 2015-07-31 CN CN202310193558.5A patent/CN116687887A/zh active Pending
- 2015-07-31 KR KR1020177005617A patent/KR102603897B1/ko active Active
- 2015-07-31 WO PCT/US2015/043128 patent/WO2016019253A1/en not_active Ceased
- 2015-07-31 JP JP2017505081A patent/JP6850524B2/ja active Active
- 2015-07-31 AU AU2015296142A patent/AU2015296142A1/en not_active Abandoned
- 2015-07-31 DK DK15827152.8T patent/DK3179986T3/da active
- 2015-07-31 KR KR1020237026168A patent/KR102666667B1/ko active Active
- 2015-07-31 EP EP15827152.8A patent/EP3179986B1/en active Active
- 2015-07-31 CN CN201580052364.7A patent/CN107072947A/zh active Pending
- 2015-07-31 PL PL15827152.8T patent/PL3179986T3/pl unknown
- 2015-07-31 CA CA2991760A patent/CA2991760C/en active Active
- 2015-07-31 ES ES15827152T patent/ES2942297T3/es active Active
-
2020
- 2020-05-26 AU AU2020203437A patent/AU2020203437B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3179986A4 (en) | 2018-02-07 |
| KR102666667B1 (ko) | 2024-05-17 |
| AU2020203437A1 (en) | 2020-06-11 |
| EP4218734A1 (en) | 2023-08-02 |
| KR102603897B1 (ko) | 2023-11-20 |
| CN107072947A (zh) | 2017-08-18 |
| KR20230119032A (ko) | 2023-08-14 |
| AU2015296142A1 (en) | 2017-02-23 |
| EP3179986A1 (en) | 2017-06-21 |
| KR20170039255A (ko) | 2017-04-10 |
| WO2016019253A1 (en) | 2016-02-04 |
| CN116687887A (zh) | 2023-09-05 |
| JP2017523189A (ja) | 2017-08-17 |
| JP6850524B2 (ja) | 2021-03-31 |
| EP3179986B1 (en) | 2023-03-15 |
| AU2020203437B2 (en) | 2020-09-17 |
| PL3179986T3 (pl) | 2023-06-26 |
| CA2991760C (en) | 2025-05-06 |
| CA2991760A1 (en) | 2016-02-04 |
| WO2016019253A9 (en) | 2016-05-12 |
| ES2942297T3 (es) | 2023-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3107548T3 (da) | Tørpulverformuleringer til inhalation | |
| EP3283148C0 (en) | PARTIAL DOSAGE DELIVERY DRY POWDER INHALERS | |
| BR112016025295A2 (pt) | Inalador de pó seco | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| HUE042087T2 (hu) | Inhalátor | |
| DK3505209T3 (da) | Pulverinhalator | |
| DK3325059T3 (da) | Tørpulverinhalator | |
| ZA201703077B (en) | Dry powder inhaler | |
| PL3541200T3 (pl) | Formulacje proszkowe | |
| GB201419091D0 (en) | Formulations | |
| DK3138600T3 (da) | Tørpulverinhalator | |
| PL3212237T3 (pl) | Formulacja metotreksatu | |
| IL263365A (en) | Dry powder inhaler | |
| EP4205699C0 (en) | INHALER | |
| IL251665A0 (en) | Dry powder formulation | |
| DK3179986T3 (da) | Tørpulverformuleringer til inhalation | |
| IL249774A0 (en) | Dry powder nebulizer | |
| IL249773A0 (en) | Breaks up lumps of dry powder medicine | |
| HUE040504T2 (hu) | Lélegzõvel mûködtetett száraz por inhalátor | |
| GB2542283B (en) | Dry powder fire-fighting composition | |
| EP3181125C0 (en) | CAPSULE FORMULATION | |
| DK3212212T3 (da) | Pulverformulering | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| TH1601001973A (th) | เครื่องพ่นละอองยาผงแห้ง | |
| TH1601003283A (th) | วิธีการเตรียมองค์ประกอบผงแห้งสำหรับสูดดม |